magnesium sulfate has been researched along with Embryopathies in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo Júnior, E; Moron, AF; Nardozza, LM | 1 |
| Izbizky, G; Meller, CH; Otaño, L | 1 |
| Clark, SL; Gibbs, RS; Reeves, SA | 1 |
| Dede, H; Gelisen, O; Secilmis, O; Solaroglu, A; Suat Dede, F | 1 |
| Rouse, DJ | 1 |
| Arca, T; Kaptanoglu, AF; Kilinc, K | 1 |
| Chlubek, D; Mikołajek, W | 1 |
| Berry, SM; Blackwell, SC; Cotton, DB; Redman, ME; Refuerzo, JS; Russell, E; Sorokin, Y; Whitty, JE | 1 |
| Janeczek, S; Mittendorf, R; Pryde, PG | 1 |
| Lubbe, WF | 1 |
| Cunningham, FG; Gant, NF | 1 |
| Chestnut, DH; Dexter, F; McGrath, J; Penning, DH; Reynolds, JD | 1 |
| Duley, L; Neilson, JP | 1 |
| Evans, JB; Hallak, M; Hotra, JW; Kupsky, WJ | 1 |
| Hallak, M; Hotra, JW; Kupsky, WJ | 1 |
| Standley, CA | 1 |
| Bolte, AC; Dekker, GA; van Geijn, HP | 1 |
| Ramsey, PS; Rouse, DJ | 1 |
| Besinger, RE; Gianopoulos, JG; Mittendorf, R; Pryde, PG | 1 |
| Boileau, PA; Turcot, MJ | 1 |
7 review(s) available for magnesium sulfate and Embryopathies
| Article | Year |
|---|---|
[Efficiency and safety of magnesium sulfate treatment in obstetrics].
Topics: Adrenergic beta-Agonists; Female; Fetal Diseases; Humans; Infant, Newborn; Magnesium Sulfate; Maternal-Fetal Exchange; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents | 2002 |
Risk-benefit effects of tocolytic therapy.
Topics: Adrenergic beta-Agonists; Adult; Calcium Channel Blockers; Cerebral Hemorrhage; Cerebral Palsy; Cyclooxygenase Inhibitors; Female; Fetal Diseases; Hormone Antagonists; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Oxytocin; Pre-Eclampsia; Pregnancy; Risk Assessment; Tocolysis; Tocolytic Agents | 2004 |
Hypertension in pregnancy. Pathophysiology and management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clonidine; Diazoxide; Diuretics; Drug Therapy, Combination; Female; Fetal Diseases; Hemodynamics; Humans; Hydralazine; Hypertension; Hypnotics and Sedatives; Labetalol; Magnesium Sulfate; Pregnancy; Pregnancy Complications, Cardiovascular; Reserpine; Sympatholytics; Tranquilizing Agents | 1984 |
Management of eclampsia.
Topics: Adult; Anticonvulsants; Antihypertensive Agents; Eclampsia; Female; Fetal Diseases; Fetus; Humans; Hydralazine; Magnesium Sulfate; Pregnancy; Pulmonary Edema; Time Factors | 1994 |
Management and monitoring of severe preeclampsia.
Topics: Adrenal Cortex Hormones; Antihypertensive Agents; Blood Pressure Determination; Female; Fetal Diseases; HELLP Syndrome; Hemodynamics; Humans; Hypertension; Labor, Obstetric; Magnesium Sulfate; Nimodipine; Plasma Substitutes; Plasma Volume; Pre-Eclampsia; Pregnancy; Seizures | 2001 |
Magnesium sulfate as a tocolytic agent.
Topics: Adrenergic beta-Agonists; Female; Fetal Diseases; Humans; Magnesium Sulfate; Maternal-Fetal Exchange; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents | 2001 |
Adverse and beneficial effects of tocolytic therapy.
Topics: Adrenergic beta-Agonists; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Female; Fetal Death; Fetal Diseases; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Oxytocin; Pregnancy; Randomized Controlled Trials as Topic; Tocolytic Agents; Vasotocin | 2001 |
13 other study(ies) available for magnesium sulfate and Embryopathies
| Article | Year |
|---|---|
Procedures for fetal neuroprotection: use of magnesium sulfate.
Topics: Fetal Diseases; Humans; Magnesium Sulfate; Nervous System Diseases; Neuroprotective Agents | 2013 |
Update on the use of magnesium sulphate for fetal neuroprotection in preterm birth.
Topics: Brain Diseases; Fetal Diseases; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Practice Guidelines as Topic; Premature Birth | 2015 |
Magnesium for fetal neuroprotection.
Topics: Algorithms; Female; Fetal Diseases; Humans; Magnesium Sulfate; Nervous System Diseases; Neuroprotective Agents; Pregnancy; Premature Birth; Tocolysis; Tocolytic Agents | 2011 |
Neuroprotective effect of magnesium sulfate treatment on fetal brain in experimental intrauterine ischemia reperfusion injury.
Topics: Animals; Anticonvulsants; Brain Injuries; Brain Ischemia; Drug Evaluation, Preclinical; Female; Fetal Diseases; Magnesium Sulfate; Pregnancy; Rats; Rats, Wistar; Reperfusion Injury | 2011 |
Magnesium sulfate for fetal neuroprotection.
Topics: Cerebral Palsy; Fetal Diseases; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents | 2011 |
Magnesium sulfate protects fetal skin from intrauterine ischemia reperfusion injury.
Topics: Animals; Disease Models, Animal; Female; Fetal Diseases; Fetus; Free Radical Scavengers; Lipid Peroxidation; Magnesium Sulfate; Neutrophil Activation; Peroxidase; Pregnancy; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Skin; Thiobarbituric Acid Reactive Substances; Uterine Artery Embolization | 2012 |
The effect of intrapartum magnesium sulfate therapy on fetal cardiac troponin I levels at delivery.
Topics: Adolescent; Adult; Anticonvulsants; Chemoprevention; Cross-Sectional Studies; Delivery, Obstetric; Eclampsia; Female; Fetal Blood; Fetal Diseases; Humans; Magnesium Sulfate; Myocardial Ischemia; Pre-Eclampsia; Pregnancy; Seizures; Tocolytic Agents; Troponin I | 2002 |
Magnesium sulfate adversely affects fetal lamb survival and blocks fetal cerebral blood flow response during maternal hemorrhage.
Topics: Animals; Cerebrovascular Circulation; Female; Fetal Death; Fetal Diseases; Fetus; Hemorrhage; Hypoxia; Magnesium Sulfate; Pregnancy; Pregnancy Complications, Cardiovascular; Sheep; Tocolytic Agents | 1996 |
Magnesium sulphate and pre-eclampsia. Trial needed to see whether it's as valuable in pre-eclampsia as in eclampsia.
Topics: Anticonvulsants; Female; Fetal Diseases; Fetus; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pre-Eclampsia; Pregnancy | 1999 |
Fetal rat brain damage caused by maternal seizure activity: prevention by magnesium sulfate.
Topics: Animals; Anticonvulsants; Brain; Brain Diseases; Female; Fetal Diseases; Gestational Age; Magnesium Sulfate; Necrosis; Neurons; Pregnancy; Pregnancy Complications; Prosencephalon; Rats; Rats, Long-Evans; Rhombencephalon; Seizures | 1999 |
Magnesium sulfate protection of fetal rat brain from severe maternal hypoxia.
Topics: Animals; Body Weight; Brain; Calcium Channel Blockers; Evaluation Studies as Topic; Female; Fetal Diseases; Fetus; Hypoxia; Hypoxia-Ischemia, Brain; Magnesium Sulfate; Pregnancy; Pregnancy Complications; Random Allocation; Rats; Rats, Long-Evans | 2000 |
Magnesium and fetal brain damage.
Topics: Animals; Brain Diseases; Female; Fetal Diseases; Magnesium Sulfate; Pregnancy; Rats; Seizures | 2001 |
[Para-cervical block in obstetrics. Preliminary studies on bupivacaine and the use of magnesium sulfate in the control of fetal bradycardia].
Topics: Adolescent; Adult; Anesthesia, Conduction; Anesthesia, Obstetrical; Blood Pressure; Bradycardia; Bupivacaine; Female; Fetal Diseases; Heart Rate; Humans; Labor, Obstetric; Magnesium Sulfate; Pregnancy; Time Factors | 1972 |